Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Zimmer, Smith & Nephew grow product offerings

This article was originally published in Clinica

Executive Summary

Last week saw both Zimmer and Smith & Nephew (S&N) ink deals to expand their ever-growing portfolios. Zimmer and tissue-based implant innovator Regeneration Technologies, of Alachua, Florida, signed an exclusive 10-year distribution agreement for a new allograft bone paste. The paste is designed to be administered in a moldable formulation, and has cohesive properties that are sustained in a wet environment, so that the implant could pack easily into the surgical site. Zimmer expects to receive the first shipments of the product in the fourth quarter of 2007. S&N expanded its orthopaedic cement offerings by entering an agreement to market and sell French firm Teknimed's Spine Fix bone cement in North America, Europe and Australia. Spine Fix is a self-hardening, ready-to-use bone cement for treatment of spinal compression fractures. It will be made available to the US market during the third quarter of 2007.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT048428

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel